Spearhead Capital Advisors, LLC Abbott Laboratories Transaction History

Spearhead Capital Advisors, LLC

$92.3 Million
Q3 2022

A detailed history of Spearhead Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Spearhead Capital Advisors, LLC holds 9,618 shares of ABT stock, worth $1.1 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

9,618

Previous 77,987 87.67%

Holding current value

$1.1 Million

Previous $8.47 Million 89.01%

% of portfolio

1.01%

Previous 1.26%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $6.62 Million - $7.66 Million	-68,369 Reduced 87.67%	9,618 $931,000
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $80,533 - $97,338	789 Added 1.02%	77,987 $8.47 Million
Q1 2022 Apr 28, 2022	BUY	$114.02 - $139.04 $348,103 - $424,489	3,053 Added 4.12%	77,198 $9.14 Million
Q4 2021 Jan 25, 2022	BUY	$115.53 - $141.46 $216,618 - $265,237	1,875 Added 2.59%	74,145 $10.4 Million
Q3 2021 Oct 27, 2021	BUY	$116.66 - $129.06 $306,465 - $339,040	2,627 Added 3.77%	72,270 $8.54 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $165,243 - $194,515	1,562 Added 2.29%	69,643 $8.07 Million
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $139,641 - $164,519	1,283 Added 1.92%	68,081 $8.16 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $477,225 - $520,038	4,545 Added 7.3%	66,798 $7.31 Million
Q3 2020 Oct 16, 2020	BUY	$91.64 - $111.29 $55,900 - $67,886	610 Added 0.99%	62,253 $6.78 Million
Q2 2020 Jul 16, 2020	SELL	$76.57 - $98.0 $40,122 - $51,352	-524 Reduced 0.84%	61,643 $5.64 Million
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $192,857 - $282,010	3,070 Added 5.19%	62,167 $4.91 Million
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $250,054 - $278,369	3,185 Added 5.7%	59,097 $5.13 Million
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $2,946 - $3,194	-36 Reduced 0.06%	55,912 $4.68 Million
Q2 2019 Jul 17, 2019	BUY	$72.88 - $85.0 $145,468 - $169,660	1,996 Added 3.7%	55,948 $4.71 Million
Q1 2019 Apr 23, 2019	BUY	$66.22 - $80.06 $87,410 - $105,679	1,320 Added 2.51%	53,952 $4.31 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $160,359 - $181,664	-2,446 Reduced 4.44%	52,632 $3.81 Million
Q3 2018 Oct 11, 2018	BUY	$60.81 - $73.36 $3.35 Million - $4.04 Million	55,078 New	55,078 $3.94 Million
Q2 2018 Jul 25, 2018	SELL	$57.57 - $63.54 $3.2 Million - $3.53 Million	-55,543 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$56.27 - $63.62 $3.13 Million - $3.53 Million	55,543 New	55,543 $3.33 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.

Account

Spearhead Capital Advisors, LLC Abbott Laboratories Transaction History